Metabolic signatures imaged in cancer-induced cachexia

Cancer Research

Volumn 71, Issue 22, 2011, Pages 6948-6956

  Penet, Marie France ^a   Gadiya, Mayur M ^a   Krishnamachary, Balaji ^a   Nimmagadda, Sridhar ^a   Pomper, Martin G ^a,b   Artemov, Dmitri ^a,b   Bhujwalla, Zaver M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; FLUORODEOXYGLUCOSE F 18; PHOSPHORYLCHOLINE; SUCCINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CONTROLLED STUDY; HISTOLOGY; IMAGE ANALYSIS; IN VIVO STUDY; LIPID METABOLISM; MALE; MALIGNANT NEOPLASTIC DISEASE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE SEQUENCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

ANIMALS; BRAIN; CACHEXIA; CELL LINE, TUMOR; CHOLINE; FLUORODEOXYGLUCOSE F18; GLUCOSE; LUNG; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, SCID; MUSCLE, SKELETAL; NEOPLASMS, EXPERIMENTAL; POSITRON-EMISSION TOMOGRAPHY;

EID: 81155126056     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1095     Document Type: Article

References (32)

1. Tisdale MJ. Cancer cachexia. Langenbecks Arch Surg 2004;389:299-305. (Pubitemid 39128544)
2. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002;52:72-91. (Pubitemid 34256834)
3. Tisdale MJ, Dhesi JK. Inhibition of weight loss by omega-3 fatty acids in an experimental cachexia model. Cancer Res 1990;50:5022-6. (Pubitemid 20257929)
4. Loberg RD, Bradley DA, Tomlins SA, Chinnaiyan AM, Pienta KJ. The lethal phenotype of cancer: the molecular basis of death due to malignancy. CA Cancer J Clin 2007;57:225-41. (Pubitemid 47312082)
5. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009;89:381-410.
6. Cannon T, Couch M, Yin X, Guttridge D, Lai V, Shores C. Comparison of animal models for head and neck cancer cachexia. Laryngoscope 2007;117:2152-8. (Pubitemid 351339589)
7. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. Characterization of a cancer cachectic factor. Nature 1996;379: 739-42. (Pubitemid 26061738)
8. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001;294:1704-8. (Pubitemid 33104839)
9. Siddiqui RA, Hassan S, Harvey KA, Rasool T, Das T, Mukerji P, et al. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice. Br J Nutr 2009;102: 967-75.
10. Peters SJ, van Helvoort A, Kegler D, Argiles JM, Luiking YC, Laviano A, et al. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice. Oncol Rep 2011;26:247-54.
11. O'Connell TM, Ardeshirpour F, Asher SA, Winnike JH, Yin X, George J, et al. Metabolomic analysis of cancer cachexia reveals distinct lipid and glucose alterations. Metabolomics 2008;4:216-25.
12. Mahony SM, Beck SA, Tisdale MJ. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour. Br J Cancer 1988;57:385-9.
13. Eley HL, McDonald PS, Russell ST, Tisdale MJ. Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition. Cancer Chemother Pharmacol 2009;63:651-9.
14. Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 1999;41:649-56. (Pubitemid 29205710)
15. Bolan PJ, Meisamy S, Baker EH, Lin J, Emory T, Nelson M, et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 2003;50:1134-43. (Pubitemid 37494015)
16. Glunde K, Raman V, Mori N, Bhujwalla ZM. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Cancer Res 2005;65:11034-43. (Pubitemid 41713374)
17. Krishnamachary B, Glunde K, Wildes F, Mori N, Takagi T, Raman V, et al. Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft. Cancer Res 2009;69:3464-71.
18. Pearlman JD, Zajicek J, Merickel MB, Carman CS, Ayers CR, Brookeman JR, et al. High-resolution 1H NMR spectral signature from human atheroma. Magn Reson Med 1988;7:262-79.
19. Zietkowski D, Davidson RL, Eykyn TR, De Silva SS, Desouza NM, Payne GS. Detection of cancer in cervical tissue biopsies using mobile lipid resonances measured with diffusion-weighted (1)H magnetic resonance spectroscopy. NMR Biomed 2010;23:382-90.
20. Wallace JC, Raaphorst GP, Somorjai RL, Ng CE, Fung Kee Fung M, Senterman M, et al. Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis. Magn Reson Med 1997;38:569-76. (Pubitemid 27419221)
21. Glunde K, Jacobs MA, Bhujwalla ZM. Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn 2006;6:821-9. (Pubitemid 44903998)
22. Ramirez de Molina A, Gutierrez R, Ramos MA, Silva JM, Silva J, Bonilla F, et al. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy. Oncogene 2002;21:4317-22. (Pubitemid 34753838)
23. Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez- Pineiro L, Sanchez J, Bonilla F, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun 2002;296:580-3.
24. Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002;94:1197-203. (Pubitemid 34993869)
25. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303-24.
26. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002;2:683-93. (Pubitemid 37328919)
27. Gatenby RA, Gillies RJ. Glycolysis in cancer: a potential target for therapy. Int J Biochem Cell Biol 2007;39:1358-66. (Pubitemid 47031043)
28. Perrine SA, Michaels MS, Ghoddoussi F, Hyde EM, Tancer ME, Galloway MP. Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat. NMR Biomed 2009;22:419-25.
29. Ryden M, Agustsson T, Laurencikiene J, Britton T, Sjolin E, Isaksson B, et al. Lipolysis-not inflammation, cell death, or lipogenesis-is involved in adipose tissue loss in cancer cachexia. Cancer 2008;113:1695-704.
30. Schneeberger AL, Thompson RT, Driedger AA, Finley RJ, Inculet RI. Effect of cancer on the in vivo energy state of rat liver and skeletal muscle. Cancer Res 1989;49:1160-4. (Pubitemid 19074829)
31. Couch M, Lai V, Cannon T, Guttridge D, Zanation A, George J, et al. Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment. Head Neck 2007;29:401-11. (Pubitemid 46623505)
32. Gehman KE, Inculet RI, Brauer M, Marsh GD, Driedger AA, Thompson RT. Early detection of cancer cachexia in the rat using 31P magnetic resonance spectroscopy of the liver and a fructose stress test. NMR Biomed 1996;9:271-5.